Professor Moon seeks to combine academically rigorous research and analysis with policy relevance and impact. Her work is broadly concerned with the intersection of global governance and public health. Her theoretical contributions to the field include conceptualizing the global health system, defining the functions the system must perform to adequately protect public health, global public goods for health, and identifying the types of governance gaps and power disparities that contribute to health inequity. She has developed specialized policy expertise on how to achieve more globally equitable innovation and access to medicines; strengthen the global governance of outbreak preparedness and response; make trade, investment and intellectual property rules more health-sensitive; and address perennial weaknesses in development assistance for health. Her current research projects focus on the international sharing of outbreak-prone pathogens and related benefits, and new business models of pharmaceutical R&D. She also directs the Knowledge Network on Innovation and Access to Medicines, a project that aims to maximize the contributions of research and analysis to strengthening the pharmaceutical innovation system, a topic she has researched for over twenty years.
Prior to joining the Graduate Institute in 2016, she was Lecturer on Global Health at the Harvard T.H. Chan School of Public Health. She was Study Director of the Harvard-LSHTM Independent Panel on the Global Response to Ebola, head of Harvard’s research team on the Lancet Commission on Global Governance for Health, and co-directed the Project on Innovation and Access to Technologies for Sustainable Development at the Kennedy School of Government. She also co-founded and led the Forum on Global Governance for Health, a focal point at the university for research, debate and strategic convening on issues at the intersection of global governance and health. She has continued to teach and advise doctoral students as adjunct Lecturer at the Harvard Chan School.
Her work has been published in leading academic journals and covered in mainstream media. Professor Moon speaks regularly at academic conferences, government and intergovernmental meetings, legislative hearings, and civil society convenings. She has served on a number of expert advisory bodies and boards, including most recently as Secretary of the Board of Directors of the Drugs for Neglected Diseases initiative, WHO Fair Pricing Forum Advisory Group, Expert Advisory Group to the UN Secretary General’s High-Level Panel on Access to Medicines, Proposal Review Committee of UNITAID, and US National Academies of Medicine Forum on Antimicrobial Threats. She is currently the Principal Investigator on three research projects, and the recipient of a PRIMA grant from the Swiss National Science Foundation. She received a BA in history from Yale, an MPA in international relations from Princeton, and PhD in public policy from the Harvard Kennedy School of Government.